About Medinice
Medinice is a publicly listed company based in Kielce (Poland) founded in 2012. A platform is operated to support medical device development. Medinice has raised $2.46 million across 2 funding rounds. Medinice offers products and services including PacePress and CoolCryo. Its focus areas include Healthcare Projects. Its legal entity is Medinice S.A.
Company details
Medinice was established in 2012 and is based in Kielce, Poland. Operations are centered on a digital platform that facilitates the development of medical devices within the healthcare technology sector. Services include tools and resources for design, prototyping, and regulatory compliance, aiding innovators and manufacturers. The focus remains on streamlining processes for medical product advancement across European markets.
- Headquarters Kielce, Poland
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website medinice.pl
- Social LinkedIn Facebook YouTube
- Legal Name Medinice Sa
- Net Profit-$1.87 M (USD)-117.89as on Dec 31, 2025
- EBITDA-$1.83 M (USD)-48.23as on Dec 31, 2025
- Total Equity Funding$2.46M (USD)
in 2 rounds
- Latest Funding Round$1.35M (USD), Series A
Sep 2018
Products & Services of Medinice
Medinice offers a comprehensive portfolio of products and services, including PacePress and CoolCryo.
PacePress is utilized for faster recovery after CIED implantations in cardiology.
CoolCryo is employed as a method for treating heart conditions through cryogenic techniques.
Funding Insights of Medinice
Medinice has successfully raised a total of $2.46M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.35 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.46M
- Total Rounds 2
- Last Round Series A — $1.35M
- First Round $1.1M
(Jul 2017)
All 2 funding rounds of Medinice with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $1.35M | Series A | – | – | – |
| Jul 2017 | $1.1M | Seed | – | – | – |
People of Medinice
4 people are tracked at Medinice (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Sanjeev Choudhary | CEO | Leadership |
Arkadiusz Dorynek | Chief Financial Officer | Leadership |
Grzegorz Wróblewski | Chief Technology Officer | Leadership |
Natalia Filipów | Specjalista Ds. Jakości I Certyfikacji | Team |
Complete people profiles for Medinice
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Medinice
Medinice is a publicly listed company on the GPW with ticker symbol ICE in Poland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Sep 2018
- Listed onWSE: ICE
- Listed entityMediNice SA
- Exchange sectorHealth technology
- ISINPLMDNCE00016
- Share price57.00 PLN (-0.87% on the day) · 2026-10-14
- Market capitalisation600,969,198.00 PLN
- Price to earnings2.2
- EPS (diluted, trailing year)-0.93 PLN
- Volume (last session)3,254
Financials of Medinice
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | -6.7M PLN | -6.6M PLN | |
| 2024 | 188,000 PLN | 37.6M PLN | -4.4M PLN |
| 2023 | 225,000 PLN | -5.1M PLN | -5.4M PLN |
| 2022 | 246,000 PLN | -4.9M PLN | -4.4M PLN |
| 2021 | 285,000 PLN | -2.9M PLN | -3.2M PLN |
Detailed financial statements for Medinice
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Medinice
4 dated milestones of Medinice across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Medinice is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $1.4M.
- IPO Lists on the stock exchange (IPO).
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medinice
Complete news archive for Medinice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medinice
Medinice was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Medinice is headquartered in Kielce, Poland. It is registered at Kielce, Swietokrzyskie, Poland.
Medinice is a funded company, having raised a total of $2.46M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Jul 2017.
Medinice was established in 2012 and is based in Kielce, Poland. Operations are centered on a digital platform that facilitates the development of medical devices within the healthcare technology sector. Services include tools and resources for design, prototyping, and regulatory compliance, aiding innovators and manufacturers. The focus remains on streamlining processes for medical product advancement across European markets.
Medinice offers PacePress and CoolCryo.
Yes, Medinice is publicly traded on GPW under the ticker symbol ICE.
Medinice operates through Medinice S.A..